Top Growth Stock for 2025: HCA Healthcare

HCA Healthcare is the largest non-governmental operator of acute care hospitals in the US, with a Zacks Rank of #3 and a Growth Style Score of A. Earnings are expected to grow 18.9% YoY for the current fiscal year, and sales growth is expected to be 6.1%. The Zacks Consensus Estimate has increased $0.85 to $26.11 per share for 2025, and HCA boasts an average earnings surprise of 7%. With solid fundamentals and a good Zacks Rank, HCA should be on investors' short lists.

HCA Healthcare Inc. (HCA), one of the largest non-governmental operators of acute care hospitals in the United States, reported robust second-quarter 2025 financial results, underscoring its strong operational performance and growth prospects. The company's stock, with a Zacks Rank of #3 and a Growth Style Score of A, has seen its earnings and sales growth expectations increase, making it a compelling investment opportunity for investors.

Financial Performance

In the second quarter of 2025, HCA Healthcare reported revenues of $18.605 billion, marking a 6.4% increase from the same period last year. Net income surged by 13.1% to $1.653 billion, while diluted earnings per share (EPS) grew by 23.5% to $6.83. The company's cash flows from operations more than doubled to $4.210 billion, reflecting its operational efficiency and financial health.

Key operational metrics also demonstrated positive trends. Same facility admissions rose by 1.8%, and emergency room visits increased by 1.3%. The company's Adjusted EBITDA reached $3.733 billion, up from $3.353 billion year-over-year.

Dividends and Share Repurchases

HCA Healthcare also announced a quarterly dividend of $0.72 per share and repurchased 7.031 million shares for $2.505 billion during the quarter. These actions highlight the company's commitment to shareholder value and financial stability.

Guidance and Outlook

Following the strong Q2 2025 results, HCA Healthcare raised its 2025 guidance, now expecting revenues between $74.00-$76.00 billion and diluted EPS of $25.50-$27.00. The company's earnings growth is expected to be 18.9% year-over-year, while sales growth is projected to be 6.1%. The Zacks Consensus Estimate has increased $0.85 to $26.11 per share for 2025, reflecting investors' optimism about HCA's growth prospects.

Upcoming Investor Events

HCA Healthcare is scheduled to present at the upcoming Wells Fargo 2025 Healthcare Conference on September 4, 2025, at 2:15 PM ET. Interested parties can access the live audio webcast and related presentation materials through the company's Investor Relations website at www.hcahealthcare.com.

Conclusion

HCA Healthcare's strong Q2 2025 results and positive outlook position it as a solid investment opportunity. With its robust financial performance, operational efficiency, and growth prospects, the company continues to be a leader in the healthcare sector. Investors should closely monitor HCA's upcoming presentations and earnings reports to stay informed about its evolving role in acute care delivery and outpatient services.

References

[1] https://www.stocktitan.net/news/HCA/
[2] https://www.stocktitan.net/news/HCA/